The drug firm on Monday reported a decline in its consolidated net profit
In past three months, Kwality Pharmaceuticals has zoomed 398 per cent, as compared to 12.8 per cent rise in the S&P BSE Sensex on the back of improved business outlook
Few pharma stocks are expected to weaken at higher levels.
Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business
Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest
Almost 60% of India's total bulk drug requirements are imported from China